mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
3e-05 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0009 |
mRNA |
PF-573228 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.002 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |